VolitionRx Limited's latest marketcap:
As of 06/04/2026, VolitionRx Limited's market capitalization has reached $67.17 M. According to our data, VolitionRx Limited is the 28990th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 67.17 M |
| Revenue (ttm) | 2.47 M |
| Net Income (ttm) | -24,598,042 |
| Shares Out | 103.02 M |
| EPS (ttm) | -4.21 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/14/2026 |
VolitionRx Limited's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/04/2026 | $67.17 M | -38.54% | 28990 |
| 12/31/2025 | $31.4 M | -43.53% | n/a |
| 12/31/2024 | $55.6 M | -1.42% | n/a |
| 12/29/2023 | $56.4 M | -59.66% | n/a |
| 12/30/2022 | $139.8 M | -16.84% | n/a |
| 12/31/2021 | $168.1 M | -10.35% | n/a |
| 12/31/2020 | $187.5 M | -3.75% | n/a |
| 12/31/2019 | $194.8 M | 204.38% | n/a |
| 12/31/2018 | $64 M | -17.95% | n/a |
| 12/29/2017 | $78 M | -34.56% | n/a |
Company Profile
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally.
It offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis such as sepsis; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.
VolitionRx Limited is based in Henderson, Nevada.
Frequently Asked Questions
-
What is VolitionRx Limited's (VNRX) current market cap?As of 06/04/2026, VolitionRx Limited (including the parent company, if applicable) has an estimated market capitalization of $67.17 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does VolitionRx Limited (VNRX) rank globally by market cap?VolitionRx Limited global market capitalization ranking is approximately 28990 as of 06/04/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.